Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
Status:
Completed
Trial end date:
2018-12-20
Target enrollment:
Participant gender:
Summary
Bone marrow MSCs will be isolated from allogenic donors, expanded under hypoxic conditions
using medium containing no serum or animal-derived reagents, and applies for Phase Ⅰ/Ⅱ study
in treating 18 recipients with ischemic limb diseases.